|
May 17
|
Applied DNA Sciences Second Quarter 2025 Earnings: Misses Expectations
|
|
May 15
|
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot
|
|
May 15
|
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results
|
|
May 14
|
Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
|
|
Apr 21
|
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
|
|
Mar 12
|
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
|
|
Feb 14
|
Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...
|
|
Feb 13
|
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot
|
|
Feb 12
|
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
|
|
Feb 11
|
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
|
|
Oct 9
|
Applied DNA Sciences Inc (APDN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines ...
|
|
Sep 11
|
Applied DNA Launches Mpox Clade I and Clade II Testing Service
|
|
Sep 11
|
LRQA Teams With Applied DNA Sciences for Cotton Traceability Pilot in Pakistan
|
|
Sep 9
|
Applied DNA bags LRQA isotopic testing pilot project in Pakistan
|
|
Aug 23
|
US Equities Markets Close Higher Friday As Powell Hints Easing of Monetary Policy
|
|
Aug 23
|
Top Midday Gainers
|
|
Aug 8
|
Applied DNA Sciences (APDN) Tops Q3 Earnings Estimates
|
|
Aug 8
|
Applied DNA Sciences: Fiscal Q3 Earnings Snapshot
|
|
Aug 8
|
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
|
|
Aug 7
|
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
|